Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAIN trial: Guanfacine effects on resting-state brain networks in children with ADHD
jRCTs051250210Recruiting
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of guanfacine in attention deficit hyperactivity disorder (ADHD) (2 arms). Primary endpoint: Resting-state functional connectivity change. Started Jun 2026; status: recruiting.
02
Drugs
guanfacine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on jRCTs051250210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051250210.